Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project Estate Transparency Concerns Family Accuses Executor of Potential Mismanagement Workday Shares Rise 5 After Company Lifts Margin Forecast Citing Artificial Intelligence Progress Iran Blinking Over Strait of Hormuz Could Open Key Oil Route Says ExCIA Chief Petraeus Microsofts AI Adoption Reveals Costly Paradox Automation May Be More Expensive Than Human Labor Momentus Stock Surges Nearly 300 in Two Days as Space Company Secures Additional Financing Service Properties Trust Q1 2026 Earnings Net Loss Widens Sharply Shares Edge Higher Despite Miss SSM Q1 2026 Earnings Loss per Share of 059 as PreRevenue Development Continues Sylvamo Corporation SLVM Q1 2026 Earnings A Wide Earnings Miss Amidst Market Headwinds Immunovant Q1 2026 Earnings WiderThanExpected Loss as Pipeline Investment Continues FWRD Q1 2026 Earnings EPS Misses Estimates Amidst Operational Headwinds Infinity Natural Resources Inc INR Q1 2026 Earnings EPS Surges 26795 Above Estimates Amid Operational Gains JELDWEN Holdings Surges Over 13 as Stock Approaches Key Resistance Level Zymeworks Inc ZYME Faces Selling Pressure as Shares Dip 240 Key Levels in Focus EHI Western Asset Global High Income Fund Edges Higher Holding Near Key Support Fifth Third Bancorp Preferred FITBP Rises 076 as Shares Consolidate Near Support Valneva VALN Surges 479 as Key Support Holds Resistance in Focus PDF Solutions Q1 2026 Earnings Strong EPS Beat Fails to Boost Stock Anthropic Microsoft in Talks for Custom AI Chip Deal Following 5 Billion Investment Auto Ancillary Giants Power Growth Through Premiumization and EV Expansion MNOV Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances MEOH Q1 2026 Earnings EPS Misses Estimates as Stock Declines Boston Omaha Corporation BOC Q4 2025 Earnings Significant EPS Miss Exceeds Estimates Stock Edges Higher Weekly Jobless Claims Drop to Lowest Since MidMay Labor Market Remains Resilient JFIN Q4 2024 Earnings Strong EPS Performance Drives Stock Rally Bicara Therapeutics BCAX Surges 4 on Renewed Buying Interest Resistance Level in Sight